stockportfolio.pro
Sarepta Therapeutics, Inc. Net Income 2009–2025
Sarepta Therapeutics, Inc. (SRPT) annual net income by fiscal year, computed from SEC filings.
| Fiscal year | Net Income | Net margin | Change (YoY) |
|---|---|---|---|
| FY 2025 | $-713.41M | -32.5% | -403.3% |
| FY 2024 | $235.24M | 12.4% | +143.9% |
| FY 2023 | $-535.98M | -43.1% | +23.8% |
| FY 2022 | $-703.49M | -75.4% | -68.0% |
| FY 2021 | $-418.78M | -59.7% | +24.4% |
| FY 2020 | $-554.13M | -102.6% | +22.5% |
| FY 2019 | $-715.08M | -187.8% | -97.6% |
| FY 2018 | $-361.92M | -120.2% | -614.0% |
| FY 2017 | $-50.69M | -32.8% | +81.0% |
| FY 2016 | $-267.26M | -4930.2% | -21.5% |
| FY 2015 | $-220.03M | -17560.3% | -62.0% |
| FY 2014 | $-135.79M | -1391.7% | -21.3% |
| FY 2013 | $-111.98M | — | +7.7% |
| FY 2012 | $-121.29M | — | -5132.4% |
| FY 2011 | $-2.32M | — | +92.8% |
| FY 2010 | $-32.18M | — | -27.9% |
| FY 2009 | $-25.16M | — | — |
Source: Sarepta Therapeutics, Inc. SEC filings — income statement (10-K). Refreshed nightly.
See the full picture for Sarepta Therapeutics, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeSarepta Therapeutics, Inc. — frequently asked questions
What is Sarepta Therapeutics, Inc.'s net income?
Sarepta Therapeutics, Inc. (SRPT) reported net income of $-713.41M for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Sarepta Therapeutics, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.